Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas GROSS, MD
Children Oncology Group, USA
Study Chair - Véronique MINARD, MD
Institut Gustave Roussy, Villejuif, FRANCE
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Leuven
Leuven, Belgium
- Children Oncology Group Operations Centres
Monrovia, Canada
- the University of Hong Kong (clinical Trials Centre)
Hong Kong, China
- Institut de Cancérologie Gustave Roussy
Villejuif, France
- 2nd Dept. of Pediatrics Semmelweis Univ.
Budapest, Hungary
- Associazione Italiana Di Ematologia Ed Oncologia Pediatrica
Padova, Italy
- Emma Children'S Hospital
Amsterdam, Netherlands
- Rectorat of Medical University
Wroclaw, Poland
- Sociedad Española de Hematología Y Oncología Pediátricas
Valencia, Spain
- University of Birmingham
Birmingham, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2011
- Primary completion
- 13 Jun 2017
- Completion
- 16 Nov 2022
- Last update posted
- 9 Feb 2026
- Registered enrollment
- 482
- Registry id
- NCT01516580
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.